尊龙凯时ag官方入口

(in months from priority date)
(status on 7 June 2022)

Note that detailed information on the excusing of delays in meeting time limits before certain designated/elected Offices is contained in the corresponding National Chapters of the PCT Applicant’s Guide .

Designated/Elected Office Chapter I
(under PCT Article 22)		 Chapter II
(under PCT Article 39(1))
AE United Arab Emirates 30 30
AG Antigua and Barbuda 30 30
AL Albania 1 31 31
AM Armenia 2 31 31
AO Angola 30 30
AP African Regional Intellectual Property Organization 4 31 31
AT Austria 1 30 30
AU Australia 31 31
AZ Azerbaijan 2 30 31
BA Bosnia and Herzegovina 34 34
BB Barbados 30 30
BG Bulgaria 1 31 31
BH Bahrain 30 30
BN Brunei Darussalam 30 30
BR Brazil 30 30
BW Botswana 6 31 31
BY Belarus 2 31 31
BZ Belize 30   30 7
CA Canada 30 15 30 15
CH Switzerland 1 , 9 30 30
CL Chile  30  30
CN China          30 (32) 8          30 (32) 8
CO Colombia 31 31
CR Costa Rica 31 31
CU Cuba 30 30
CZ Czechia 1 31 31
DE Germany 1 31 31
DJ Djibouti 30 30
DK Denmark 1  31  31
DM Dominica 3 30 30
DO Dominican Republic 30 30
DZ Algeria 31 31
EA Eurasian Patent Organization 31 31
EC Ecuador 31 31
EE Estonia 1 31 31
EG Egypt 30 30
EP European Patent Organisation 10 31 31
ES Spain 1 30 30
FI Finland 1 31 31
GB United Kingdom 1 31 31
GD Grenada 3 30 30
GE Georgia 31 31
GH Ghana 6 30 30
GM Gambia 6 30 31
GT Guatemala 30 30
HN Honduras 30 30
HR Croatia 1 31 31
HU Hungary 1 31 31
ID Indonesia    31 5    31 5
IL Israel 30 30
IN India 31 31
IQ
Iraq 3 30 30
IR Iran (Islamic Republic of) 30 30
IS Iceland 1 31 31
IT Italy 1 30 16 30 16
JM
Jamaica 30 30
JO Jordan 30 30
JP Japan 30 30
KE Kenya 6 30 30
KG Kyrgyzstan 2 31 31
KH Cambodia 30 30
KN Saint Kitts and Nevis 30 30
KP Democratic People’s Republic of Korea 30 30
KR Republic of Korea 31 31
KW Kuwait 30 30
KZ Kazakhstan 2 31 31
LA Lao People’s Democratic Republic 31 31
LC Saint Lucia 3 30 30
LK Sri Lanka 30 30
LR Liberia 6 30 31
LS Lesotho 6 30 31
LU Luxembourg 1     20 11 30
LY Libya 3 30 30
MA Morocco 31 31
MD Republic of Moldova 31 31
ME Montenegro 3 30 30
MG Madagascar 30 30
MK North Macedonia 1 31 31
MN Mongolia 31 31
MW Malawi 6 30 30
MX Mexico 30 30
MY Malaysia 30 30
MZ Mozambique 6 31 31
NA Namibia 6 31 31
NG Nigeria 30 30
NI Nicaragua 30 30
NO Norway 1 31 31
NZ New Zealand 31 31
OA African Intellectual Property Organization 12 30 30
OM Oman 30 30
PA Panama 30 30
PE Peru  30  30
PG Papua New Guinea 31 31
PH Philippines           30 (31 8 )           30 (31 8 )
PL Poland 1 30 30
PT Portugal 1 30 30
QA Qatar 30 30
RO Romania 1 30 30
RS Serbia 1     30 13 30 13
RU Russian Federation 2 31 31
RW Rwanda 3 , 6 30 30
SA Saudi Arabia 30 30
SC Seychelles 31 31
SD Sudan 6 30 30
SE Sweden 1 31 31
SG Singapore 30 14 30 14
SK Slovakia 1 31 31
SL Sierra Leone 6 31 31
ST Sao Tome and Principe 3 , 6 30 30
SV El Salvador 30 30
SY Syrian Arab Republic 31 31
TH Thailand 30 30
TJ Tajikistan 2 30 31
TM Turkmenistan 2 30 31
TN Tunisia 30 30
TR Türkiye 1          30 (33 8 )          30 (33 8 )
TT Trinidad and Tobago 30 31
TZ United Republic of Tanzania 6     21 11 31
UA Ukraine 31 31
UG Uganda 6 30 31
US United States of America 30 30
UZ Uzbekistan 31 31
VC Saint Vincent and the Grenadines 31 31
VN Viet Nam 31 31
WS
Samoa 31 31
ZA South Africa 31 31
ZM Zambia 6 30 30
ZW Zimbabwe 6 30 31
  1. If designated/elected for a European patent, see EP as DO/EO for the applicable time limits.
  2. If designated/elected for a Eurasian patent, see EA as designated/elected Office (DO/EO) for the applicable time limits.
  3. In the absence of information from the Office concerned, the time limits shown are those which would normally apply under PCT Articles 22(1) and 39(1)(a).  If the Office decides to apply longer time limits, that information will be published in the PCT Newsletter .
  4. This Office acts as DO/EO for the following State which does not act in the capacity of DO/EO:  SZ.
  5. This time limit may be extended provided that the applicant pays an additional fee for late entry into the national phase (see national phase for details).
  6. If designated/elected for an ARIPO patent, see AP as DO/EO for the applicable time limits.
  7. May be extended upon written request of the applicant.
  8. Time limit applicable if applicant pays an additional fee for late entry into the national phase (see national phase for details: CA, CN, PH, TR).
  9. This Office acts as DO/EO for the following State which does not act in the capacity of DO/EO:  LI.
  10. This Office acts as DO/EO for the following States which do not act in the capacity of DO/EO:  BE, CY, FR, GR, IE, LT, LV, MC, MT, NL, SI, SM.
  11. This Office has notified the International Bureau of the non-applicability of the 30-month time limit under PCT Article 22(1), as modified with effect from 1 April 2002 – it does not yet apply the 30-month time limit for entering the national phase.
  12. This Office acts as DO/EO for the following States which do not act in the capacity of DO/EO:  BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG.
  13. The time limit may be extended by 30 days if the applicant pays an additional fee for late entry into the national phase.
  14. The time limit may be extended by up to 18 months provided the applicant pays the prescribed fee (see national phase for details).
  15. Up to 12 months after the 30-month deadline (30 months from the priority date) the applicant can request reinstatement of rights provided that he/she pays the fee for reinstatement of rights and meets the other requirements outlined in subsection 154(3) of the Canadian Patent Rules for the reinstatement of rights (late entry into the national phase).
  16. For international applications filed on or after 1 July 2020.